Vor Biopharma Says FDA Grants Fast Track Designation To VOR33 For Acute Myeloid Leukemia
10/9 08:37
(RTTNews) - Vor Biopharma (VOR), a clinical-stage cell and genome engineering company, announced that its VOR33 was granted Fast Track designation by the U.S. Food and Drug Administration. VOR33 is Vor's lead engineered hematopoietic stem cell or eHSC therapeutic candidate for th...